Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cell Chemical Biology|July 18, 2020
In Vitro and Cellular Probes to Study PARP Enzyme Target EngagementTim J Wigle, Danielle J Blackwell, Laurie B Schenkel, et al.Journal of Medicinal Chemistry|March 5, 2016
Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo ActivityLaurie B Schenkel, Philip R Olivieri, Alessandro A Boezio, et al.Journal of Medicinal Chemistry|November 18, 2011
Discovery of potent and highly selective thienopyridine Janus kinase 2 inhibitorsLaurie B Schenkel, Xin Huang, Alan Cheng, et al.Chembiochem : a European Journal of Chemical Biology|April 10, 2021
Targeted Degradation of PARP14 Using a Heterobifunctional Small MoleculeTim J Wigle, Yue Ren, Jennifer R Molina, et al.Cancer Research|October 12, 2010
Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell linesMarc Payton, Tammy L Bush, Grace Chung, et al.Cell Chemical Biology|March 11, 2021
A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explantsLaurie B Schenkel, Jennifer R Molina, Kerren K Swinger, et al.Bioorganic & Medicinal Chemistry Letters|March 8, 2011
Discovery of triazine-benzimidazoles as selective inhibitors of mTOREmily A Peterson, Paul S Andrews, Xuhai Be, et al.Journal of Medicinal Chemistry|July 22, 2016
Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 InhibitorsErin F DiMauro, Stephen Altmann, Loren M Berry, et al.Journal of Medicinal Chemistry|May 14, 2015
Discovery of N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), a highly selective, orally bioavailable inhibitor of aurora kinases with activity against multidrug-resistant cancer cell linesStephanie Geuns-Meyer, Victor J Cee, Holly L Deak, et al.Journal of Medicinal Chemistry|August 6, 2010
Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitorVictor J Cee, Laurie B Schenkel, Brian L Hodous, et al.Pageof 2